Intranodal injection of anticancer drugs into fixed cervical metastatic lymph nodes

Oral Diseases

Volumn 3, Issue 4, 1997, Pages 247-253

  Osaki, T ^a   Ueta, E ^a   Yoneda, K ^a   Yamamoto, T ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

Intranodal injection; Metastatic lymph nodes; Oral carcinoma

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; COBALT 60; FLUOROURACIL; PEPLEOMYCIN;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HEAD AND NECK CANCER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRATUMORAL DRUG ADMINISTRATION; LYMPH NODE; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MALE; PRIORITY JOURNAL;

EID: 0031406350     PISSN: 1354523X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1601-0825.1997.tb00050.x     Document Type: Article

References (19)

1. Bachaud JM, Cohen-Jonathan E, Alzieu C et al (1996). Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced head and neck carcinoma: final report of a randomized trial. Int J Radiat Oncol 36: 999-1004.
2. Banerjee S, Ganapathi R, Ghosh L et al (1992). Down-regulation of ras and myc expression associated with mdr-1 over-expression in adriamycin-resistant tumor cells. Cell Mol Biol 38: 561-570.
3. Bensmaine M el-A, Guillot T, Bernai ET et al (1996). Neoadjuvant chemotherapy with cisplatin-vindesine-5-fluorouracil and folic acid for locally advanced head and neck carcinoma. Am J Clin Oncol 19: 356-362.
4. Cho J, Lee Y, Lutzky J et al (1995). Collateral sensitivity to radiation and cis-platinum in a multidrug-resistant human leukemia cell line. Cancer Chemother Pharmacol 37: 168-172.
5. Corvo R, Giaretti W, Sanguineti G et al (1993). Potential doubling time in head and neck tumors treated by primary radiotherapy: preliminary evidence for a prognostic significance in local control. Int J Radiat Oncol 27: 1165-1172.
6. Fujiwara H, Hamaoka T (1996). Antitumor and antimetastatic effects of interleukin 12. Cancer Chemother Pharmacol 38: S22-S26.
7. Kaffenberger W, Holzer-Muller L, Auberger T et al (1995). An immunological outcome predictive score for head and neck carcinoma patients. Strahlentherapie und Onkologie 171: 444-453.
8. Kawata R, Shinomiya T, Yasuda N et al (1986). Matrix metalloproteinase-2 concentrations in squamous cell carcinoma of the head and neck and its clinical significance. J Oto-Rhino-Laryngol Soc Jap 99: 299-305.
9. Kolitz JE, Mertelsmann R (1991). The immunotherapy of human cancer with interleukin 2: present status and future directions. Cancer Invest 9: 529-542.
10. Kudoh S, Komiyama S, Miyazaki H et al (1990). Appearance of drug-resistant tumor cells in a maxillary cancer patient undergoing chemotherapy and chemoradiotherapy. Am J Otolaryngol 11: 165-169.
11. Mu J, Zou JP, Yamamoto N et al (1995). Administration of recombinant interleukin 12 prevents outgrowth of tumor cells metastasizins spontaneously to lung and lymph nodes. Cancer Res 55: 4404-4408.
12. Nakajima I, Chu TM (1992). Enhanced cell-mediated cytotoxicity by interferon-gamma and interleukin-2 against syngeneic murine mammary adenocarcinoma. Mol Biother 4: 47-52.
13. Osaki T, Hirota J, Yoneda K et al (1996). Clinical and histopathological characteristics of tongue and gingival carcinomas with occult and clinically evident cervical lymph node metastasis. Int J Oral Maxillofac Surg 25: 274-278.
14. Raaphorst GP, Bussey A, Heller DP et al (1994). Comparison of thermoradiosensitization in two human melanoma cell lines and one fibroblast cell line by concurrent mild hyperthermia and low-dose-rate irradiation. Radiat Res 137: 338-345.
15. Sauri H, Kim AT, Shau H (1995). Characterization of an oxidation-resistant tumor cell line and its sensitivity to immune response and chemotherapy. J Surg Res 58: 526-535.
16. Srinivasan JM, Fajardo LF, Hahn GM (1990). Mechanism of antitumor activity of tumor necrosis factor alpha with hyperthermia in a tumor necrosis factor alpha-resistant tumor. J Natl Cancer Inst 82: 1904-1910.
17. Tsukuda M, Tamamushi N, Mochimatsu I et al (1986). Combination chemotherapy of cisplatin. vincristine and peplomycin for patients with head and neck carcinoma. Jpn J Cancer & Chemother 13: 486-490.
18. Tsuruo T, Hamilton TC, Louie KG et al (1986). Collateral susceptibility of adriamycin-, melphalan- and cisplatin-resistant human ovarian tumor cells to bleomycin. Jpn J Cancer Res 77; 941-945.
19. Wang M, Gu XZ, Yin WB et al (1989). Randomized clinical trial on the combination of preoperative irradiation and surgery in the treatment of esophageal carcinoma: report on 206 patients. Int J Radiat Oncol Biol Phys 16: 325-327.